Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1448602404
总结
CYP2C9 *2 is associated with increased risk of Hemorrhage and Stroke when treated with acenocoumarol or warfarin in people with Atrial Fibrillation and venous thromboembolism as compared to CYP2C9 *1.